Management Team
Wilson Zhang, M.D., Chief Executive Officer
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Wilson Zhang, M.D., Chief Executive Officer
Business management executive with 20 years’ experience working in the diagnostics corporate business development sector, joint venture and international collaboration projects, and M&A activities.
Thomas Tombler, PhD, MBA, Chief Operating Officer
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Wilson Zhang, M.D., Chief Executive Officer
Biotech and nanotechnology executive with 20 years of experience in management, IP strategy, and commercializing advanced technologies.
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Kurt Wehrle serves as Vice President, Partnerships & Strategic Alliances at Intelligenome, bringing over 20 years of leadership in diagnostics and life sciences to the role. His career includes roles at Siemens Healthineers, QIAGEN, and Danaher, spanning the commercialization of novel diagnostics focused on tuberculosis. He holds an MBA f
Kurt Wehrle serves as Vice President, Partnerships & Strategic Alliances at Intelligenome, bringing over 20 years of leadership in diagnostics and life sciences to the role. His career includes roles at Siemens Healthineers, QIAGEN, and Danaher, spanning the commercialization of novel diagnostics focused on tuberculosis. He holds an MBA from the University of Chicago Booth School of Business and a B.S. in Chemical Engineering.
Bo Ning, Ph.D., Chief Technology Officer
Yuanyuan Kang, Ph.D., Senior Director, Research and Development
Kurt Wehrle Vice President, Partnerships & Strategic Alliances
Contributed the key design for CRISPR detection of TB and published a series of papers in leading peer-reviewed journals, including Nature Nanotechnology, Lancet Microbe, Science Advances, JCI, Biosensors & Bioelectronics, and Cell Reports Methods.
Yuanyuan Kang, Ph.D., Senior Director, Research and Development
Yuanyuan Kang, Ph.D., Senior Director, Research and Development
Yuanyuan Kang, Ph.D., Senior Director, Research and Development
15+ years of research in academia and industry. Experienced in the development, qualification, and validation of CLIA, cGMP, and cGLP-qualified molecular biomarker assays for preclinical and clinical trials in phases I, II, and III.
Advisory Team
Tony Hu, Ph.D., Chief Science Advisor
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Weatherhead Presidential Chair in Biotechnology Innovation
Director, Center for Intelligent Molecular Diagnostics
Professor of Biochemistry and Molecular Biology, Microbiology, and Biomedical Engineering
School of Medicine, Tulane University
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine and Director of the Central Laboratory at NewYork-Presbyterian/Weill Cornell. She serves as Chair of the IFCC Task Force on Outcome Studies in Laboratory Medicine and is President-Elect of the ADLM Academy. She is also the Past President o
Dr. Zhen Zhao is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine and Director of the Central Laboratory at NewYork-Presbyterian/Weill Cornell. She serves as Chair of the IFCC Task Force on Outcome Studies in Laboratory Medicine and is President-Elect of the ADLM Academy. She is also the Past President of the NACCCA. A leader in laboratory diagnostics,
Dr. Zhao has published over 100 peer-reviewed papers and received the IFCC Distinguished Women Scientist Award for her contributions to in vitro diagnostics.